Conditions Epilepsy Supply Chain Treatment 
The Cannigma
JUNE 25, 2022
Poland established a medical cannabis program in 2017, which allows for a range of cannabis products to be prescribed for a range of medical conditions. Qualifying conditions include chronic pain, multiple sclerosis, spasticity, chemo-induced nausea, and treatment-resistant epilepsy. Poland and cannabis.
Cannabis Law Report
JANUARY 10, 2022
This high share is attributable to the rising adoption of THCV for various applications such as epilepsy, arthritis, metabolic disorders, neurological disorders, and pain management. In 2020, the others segment accounted for the highest share in the market, owing to the increasing utilization of minor cannabinoids for health conditions.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JANUARY 24, 2022
The CBD segment dominated the market in 2021 due to the growing awareness about the positive effects of CBD for the treatment of various medical conditions, such as chronic pain, cancer & multiple sclerosis. Growing adoption of medical marijuana for treatment of chronic diseases. & Canada, hampered the market growth.
Cannabis Law Report
FEBRUARY 15, 2019
The shipment has been exported by the Office of Medical Cannabis of the Netherlands and will be delivered directly to the patients from a pharmacy in the UK, with additional stock retained to ensure continuity of supply. The Home Office eventually changed rules to allow prescriptions, but there has been little movement until now.
Veriheal
AUGUST 31, 2020
Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Nishtha Tripathi.
The Cannigma
MAY 7, 2021
It was a lot more lenient for cannabis producers to supply patients all across North America for the last 15 years and I think, it’s not only the mindset but it’s the supply chain makeup that is quite different in terms of how the market is being supplied on both sides of the Atlantic.
Cannabis Law Report
SEPTEMBER 9, 2021
Medical cannabis is used for the treatment of various chronic conditions, such as Parkinson’s disease, Alzheimer’s disease, arthritis, cancer, depression, anxiety, epilepsy, and other neurological conditions. Supply Chain Analysis. Legalization Landscape. The Netherlands. Czech Republic.
Expert insights. Personalized for you.
108 
Let's personalize your content